Read + Share
Martini G, Ciardiello D, Dallio M, Famiglietti V, et al. Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC
treated with cetuximab plus avelumab. Int J Cancer 2022;151:473-480.
PMID: 35429341
|
 |
|
Martini G, Ciardiello D, Dallio M, Famiglietti V, et al. Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC
treated with cetuximab plus avelumab. Int J Cancer 2022;151:473-480.
PMID: 35429341
|
|
|
|